APA (7th ed.) Citation

D, C., DB, S., JM, H., M, G., DF, E., AF, d. B., . . . M, F. (2016). Succinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity. Molecular neurobiology, 53(2), 1280. https://doi.org/10.1007/s12035-014-9086-x

Chicago Style (17th ed.) Citation

D, Colle, Santos DB, Hartwig JM, Godoi M, Engel DF, de Bem AF, Braga AL, and Farina M. "Succinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity." Molecular Neurobiology 53, no. 2 (2016): 1280. https://doi.org/10.1007/s12035-014-9086-x.

MLA (9th ed.) Citation

D, Colle, et al. "Succinobucol, a Lipid-Lowering Drug, Protects Against 3-Nitropropionic Acid-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Cells via Upregulation of Glutathione Levels and Glutamate Cysteine Ligase Activity." Molecular Neurobiology, vol. 53, no. 2, 2016, p. 1280, https://doi.org/10.1007/s12035-014-9086-x.